| Dir : /home/ithome/mail/cur/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/cur/1757381085.M211484P3523.host100322.itwesthosting.com,S=7865,W=8000:2, |
Return-Path: <rheumato@mdpi.com>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id MIRxDN2Bv2jDDQAAp0YrwQ
(envelope-from <rheumato@mdpi.com>)
for <ithome@host100322.itwesthosting.com>; Tue, 09 Sep 2025 03:24:45 +0200
Return-path: <rheumato@mdpi.com>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Tue, 09 Sep 2025 03:24:45 +0200
Received: from smtp-aws.biomolecules.pub ([44.228.9.243]:48318)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <rheumato@mdpi.com>)
id 1uvn6B-0000xn-2a
for senka.rendulic@bolnica-lipik.hr;
Tue, 09 Sep 2025 03:24:45 +0200
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=mdpi.com;
s=s20230307; t=1757381081;
bh=8lm543jAxhUQAo76vLvA/CFvM2G9arQ1cnt2PPyOK3c=;
h=Subject:List-Unsubscribe:From:To:Reply-To:Date:From;
b=ILpX08921GifeJnmkquRxJpuYuIXx9uOiGZP+KK2KcjRosxHocxpDHDqTz6FTlf92
27TRd3SduRrwxbSzWMsFoz1YKmX/ZcSmBm/LpAz7MHo+NbSPce34Jcp6oyHVmMTch4
czCjfVu5SwrLhyWdAgbTopS/Z2i8JLq/BnR7udJoEZMkrCJDpVXFkitW4pVKcDvwLM
Qs+viA50wyhzDW/Vp+as2ASG+78gW2df9+hqXCvKaveyzNP4g4C2CQW8xqyeknbQM+
1A7+gsZ5whZ8UG55P6Ltwzd3xjmQU3Rz4uN3WbSuLp7tt94/IdVkhoB543M0i/wt9x
M86H7MGREzbiA==
Received: from [127.0.0.1] (unknown [212.243.204.10])
by smtp-aws.biomolecules.pub (Postfix) with ESMTPS id 80D9E7DA9F
for <senka.rendulic@bolnica-lipik.hr>; Tue, 9 Sep 2025 01:24:40 +0000 (UTC)
Subject: [Rheumato] (ISSN 2674-0621) Contribution(s) to Our Journal with
Full =?utf-8?Q?Waiver=28s=29=E2=80=94Gentle?= Reminder
Message-ID: <1757381080.mmailer68bf81d845978@mdpi.com>
List-Unsubscribe: <https://www.mdpi.com/unsub/managesubscriptions/mail/c2Vua2EucmVuZHVsaWNAYm9sbmljYS1saXBpay5ocg==/78904548d51676db028a6b851383a9bef31f8dc47aeb8b4c14c826d92a79612a>
X-MSRC: 002-001-101
From: rheumato <rheumato@mdpi.com>
To: senka.rendulic@bolnica-lipik.hr
Reply-To: rheumato@mdpi.com
MIME-Version: 1.0
Date: Tue, 09 Sep 2025 03:24:40 +0200
Content-Type: multipart/alternative; boundary=XR5FlYD4
X-Spam-Status: No, score=0.6
X-Spam-Score: 6
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Dear Dr. Rendulić Slivar, We recently invited you to submit
a comprehensive review or original in-depth article in Rheumato, and were
wondering if you have considered our proposal. --The submission deadline
is 15 November 2025. If you are busy and cannot submit a paper by this deadline,
please feel free to contact us to discuss a potential extension. If you are
interested in thi [...]
Content analysis details: (0.6 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: mdpi.com]
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[44.228.9.243 listed in sa-trusted.bondedsender.org]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[44.228.9.243 listed in bl.score.senderscore.com]
0.7 MPART_ALT_DIFF BODY: HTML and text parts are different
0.1 MIME_HTML_MOSTLY BODY: Multipart message mostly text/html MIME
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
-0.0 DKIMWL_WL_HIGH DKIMwl.org - High trust sender
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
--XR5FlYD4
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: quoted-printable
--XR5FlYD4
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: quoted-printable
<p>Dear Dr. Renduli=C4=87 Slivar,</p><p>We recently invited you to submit a=
comprehensive review or original in-depth article in <em>Rheumato</em>, an=
d were wondering if you have considered our proposal.<br><br>--<strong>The =
submission deadline is 15 November 2025.</strong> If you are busy and canno=
t submit a paper by this deadline, please feel free to contact us to discus=
s a potential extension. If you are interested in this proposal, please kin=
dly send us the tentative information regarding your paper.</p><p>--An arti=
cle processing charge (APC) of CHF 1000 currently applies to each accepted =
paper. However, if you are interested in contributing a paper, <strong>you =
can enjoy a 100% discount on your submission</strong>.<br><br><strong>About=
</strong><em><strong>Rheumato<br></strong>Rheumato</em> is a peer-reviewed=
, international, scientific, and open access journal striving to publish hi=
gh-quality articles on all aspects of the field of rheumatology and to make=
them freely available to researchers worldwide.<br><br>If you would like t=
o extend the submission deadline or have any concerns, please do not hesita=
te to let me know. <br>We look forward to hearing from you within 3 days.<b=
r><br>Best regards,<br><em>Rheumato</em> Editorial Office<br><br>E-mail: <a=
href=3D"mailto:rheumato@mdpi.com" rel=3D"noopener noreferrer nofollow">rhe=
umato@mdpi.com</a><br>Rheumato: <a href=3D"https://www.mdpi.com/journal/rhe=
umato" rel=3D"noopener noreferrer nofollow">https://www.mdpi.com/journal/rh=
eumato</a> <br>Twitter: @RheumatoMDPI <br>Recruiting Editorial Board Member=
s for Rheumato: <a href=3D"https://www.mdpi.com/journal/rheumato/announceme=
nts/4178" rel=3D"noopener noreferrer nofollow">https://www.mdpi.com/journal=
/rheumato/announcements/4178</a> <br><br>MDPI, Grosspeteranlage 5<br>4052 B=
asel<br>Switzerland<br>Tel.: +41 61 683 77 34<br><a href=3D"https://www.mdp=
i.com/journal/rheumato" rel=3D"noopener noreferrer nofollow">https://www.md=
pi.com/journal/rheumato</a><br>--<br>Notice: If this message has reached yo=
u by mistake, you may ignore it. If you do not wish to receive further info=
rmation, invitations, or offers from us, you may unsubscribe at any time vi=
a the link below or by contacting us at data-protection@mdpi.ch. For more i=
nformation about how we handle your data, please see our Privacy Policy (<a=
href=3D"https://www.mdpi.com/about/privacy)." rel=3D"noopener noreferrer n=
ofollow">https://www.mdpi.com/about/privacy).</a><br>---------------------<=
/p><p>Unsubscribe: https://www.mdpi.com/unsub/managesubscriptions/mail/c2Vu=
a2EucmVuZHVsaWNAYm9sbmljYS1saXBpay5ocg=3D=3D/78904548d51676db028a6b851383a9=
bef31f8dc47aeb8b4c14c826d92a79612a</p><p></p>
--XR5FlYD4--